STAT3 and nonpapillary renal cell carcinoma: In the present study, we evaluated the prognostic value of pS727-STAT3 on a tissue microarray (TMA) from a new cohort of 82 ccRCC patients followed-up for 10 years, and we correlated its expression levels, both in the nucleus and in the cytosol, with the clinical outcome of ccRCC patients.